fda bpc-157 not approved advisory committee votes to add popular peptide to drug compounding list $HIMS Stock: FDA Panel Recommends

$HIMS Stock: FDA Panel Recommends BPC 157 Peptide BPC 157 WHY IT WILL NEVER BE FDA APPROVED Stefano M. Sinicropi, MD An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA to review 7 popular peptides touted for weight loss, healing and longevity Most FDA advisers say peptides like BPC 157 and TB 500 should be made available in the U.S. Here's what happens next. MarketWatch

SKU: 15036071179 · From aimoneimmobiliare.it